Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

7.43
+0.01000.13%
Post-market: 7.470.0400+0.54%18:24 EDT
Volume:1.04M
Turnover:7.72M
Market Cap:490.48M
PE:-1.97
High:7.62
Open:7.58
Low:7.36
Close:7.42
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:0.63
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:6.83
PE(LYR):-1.98

Loading ...

Regenxbio tells WSJ that FDA will reverse rejection of drug

TIPRANKS
·
Jun 22

Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC Says

MT Newswires Live
·
Jun 18

REGENXBIO Up Over 23%, on Pace for Largest Percent Increase Since September 2021 -- Data Talk

Dow Jones
·
Jun 18

Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Climb Bio (CLYM)

TIPRANKS
·
Jun 06

REGENXBIO Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 06

Regenxbio price target lowered to $26 from $30 at H.C. Wainwright

TIPRANKS
·
Jun 06

Regenxbio Inc. : H.c. Wainwright Cuts Target Price to $26 From $30

THOMSON REUTERS
·
Jun 06

Regenxbio shareholders approved non-executive stock option exchange program at annual meeting

Reuters
·
Jun 03

Stifel Nicolaus Sticks to Their Buy Rating for RegenXBio (RGNX)

TIPRANKS
·
May 27

Nippon Shinyaku posts FY2025 earnings call transcript

Reuters
·
May 25

Regenxbio joins RBC Global Healthcare Conference fireside chat

Reuters
·
May 19

Regenxbio price target lowered to $16 from $17 at Morgan Stanley

TIPRANKS
·
May 15

Sarepta's Elevidys Faces 'Little' Pressure After Regenxbio Data, Wedbush Says

MT Newswires Live
·
May 15

REGENXBIO Is Maintained at Overweight by Barclays

Dow Jones
·
May 15

Morgan Stanley Sticks to Its Buy Rating for RegenXBio (RGNX)

TIPRANKS
·
May 15

Analysts Have Conflicting Sentiments on These Healthcare Companies: RegenXBio (RGNX), Align Tech (ALGN) and Keros Therapeutics (KROS)

TIPRANKS
·
May 15

Regenxbio Inc : Bofa Global Research Cuts Price Objective to $14 From $25

THOMSON REUTERS
·
May 15

Regenxbio price target lowered to $14 from $25 at BofA

TIPRANKS
·
May 15

Analysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), RegenXBio (RGNX)

TIPRANKS
·
May 15

Update: Regenxbio Shares Fall After Q1 Swings to Loss, Revenue Declines; Phase 3 Study of RGX-202 Meets Primary Endpoint

MT Newswires Live
·
May 15